Provided by Tiger Trade Technology Pte. Ltd.

uniQure NV

48.37
-0.5200-1.06%
Pre-market: 48.370.00000.00%07:05 EDT
Volume:673.86K
Turnover:32.88M
Market Cap:3.36B
PE:-11.97
High:49.85
Open:48.91
Low:48.19
Close:48.89
52wk High:71.50
52wk Low:8.73
Shares:69.37M
Float Shares:57.53M
Volume Ratio:0.70
T/O Rate:1.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.0399
EPS(LYR):-3.4602
ROE:-157.61%
ROA:-15.72%
PB:10.35
PE(LYR):-13.98

Loading ...

uniQure Price Target Maintained With a $70.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 10

Chardan Raises Price Target on uniQure to $31 From $16, Keeps Buy Rating

MT Newswires Live
·
Mar 10

uniQure Is Maintained at Buy by Chardan Capital

Dow Jones
·
Mar 10

What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?

Benzinga
·
Mar 10

uniQure price target raised to $31 from $16 at Chardan

TIPRANKS
·
Mar 10

U.S. Chess Champion Sitting on Huge 42.33% uniQure (QURE) Loss

TIPRANKS
·
Mar 10

This biotech's stock is soaring after a 'polarizing' FDA official is stepping down

Dow Jones
·
Mar 09

Top Premarket Gainers

MT Newswires Live
·
Mar 09

Why Is uniQure Stock Skyrocketing Monday?

Benzinga_recent_news
·
Mar 09

Uniqure Nv : Wells Fargo Raises to Overweight From Equal Weight; Raises Target Price to $60 From $15

THOMSON REUTERS
·
Mar 09

uniQure upgraded to Overweight from Equal Weight at Wells Fargo

TIPRANKS
·
Mar 09

Uniqure Nv : RBC Raises to Outperform From Sector Perform; Raises Target Price to $35 From $11

THOMSON REUTERS
·
Mar 09

BUZZ-Uniqure jumps after FDA vaccines chief Vinay Prasad to step down

Reuters
·
Mar 07

US-Listed Shares of Uniqure Nv Rise 28%

THOMSON REUTERS
·
Mar 07

Rosen Law Firm Highlights April 13 Lead Plaintiff Deadline in uniQure Securities Class Action

Reuters
·
Mar 06

Market Chatter: UniQure's Experimental Treatment for Huntington's Disease Faces Criticism From FDA Official

MT Newswires Live
·
Mar 06

uniQure therapy called failed product by FDA official, Bloomberg says

TIPRANKS
·
Mar 06

US-Listed Shares of Uniqure Nv Rise Nearly 20%

THOMSON REUTERS
·
Mar 06

FDA Defends Call For Placebo Study In uniQure Huntington's Gene Therapy Trial

Benzinga_recent_news
·
Mar 06

uniQure call volume above normal and directionally bullish

TIPRANKS
·
Mar 06